Where your DNA places you among other people, and the studies behind it.
Not tailored to your result, and not medical advice
Quit or Avoid Smoking: Tobacco is the dominant known cause of bladder cancer. A review of environmental risk factors attributed roughly 50% of bladder cancer in men and 23% in women to cigarette smoking, and pooled summary odds ratios put current smokers at about three times the risk of non-smokers (OR 3.33, 95% CI 2.63 to 4.21) and former smokers at about twice the risk (OR 1.98, 95% CI 1.72 to 2.29). The precise mechanism has yet to be determined, but two aromatic amines present in tobacco smoke, 2-naphthylamine and 4-aminobiphenyl, are the leading candidate carcinogens. Environmental Health (PMC)
Quit as Early as Possible: Risk does fall after stopping, but it falls slowly and does not fully reset. In the Women's Health Initiative, 870 bladder cancers were identified among 143,279 postmenopausal women over an average of 14.8 years of follow-up, and smokers who quit had a lower risk than those who continued (HR 0.61, 95% CI 0.40 to 0.94). After adjusting for pack-years of smoking, risk among former smokers declined by about 25% within the first ten years of cessation and kept falling as more time passed, yet after 30 years it remained higher than in never smokers (HR 1.92, 95% CI 1.43 to 2.58). The practical reading is that stopping earlier removes more risk than stopping later. Cancer Prevention Research (PubMed)
Limit Workplace Chemical Exposure: After smoking, work exposures are the next largest identified contributor. A British analysis attributed 5.28% of bladder cancers (95% CI 3.43 to 7.72) to occupational exposure, led by mineral oils in metal machining and machine tool operation (2.81%), diesel engine exhaust in construction and land transport (1.00%), painting (0.67%), aromatic amines in dyestuff, leather and cable manufacture (0.67%), and hairdressing and barbering (0.16%). If you work or have worked around these materials, the part you control is using the extraction, gloves and respiratory protection your workplace provides, and your exposure history is worth mentioning to a clinician. British Journal of Cancer (PMC)
Take Blood in Urine Seriously: Blood in the urine is the main symptom of bladder cancer, and it can look bright pink, red or dark brown. The NHS advises asking for an urgent GP appointment or getting help from NHS 111 if you have blood in your pee, even if you have no other symptoms, even if it is the first time it has happened, and even if there is only a small amount. Other symptoms it lists include pain or burning when passing urine, needing to urinate more often or more urgently, and repeated urinary infections. The NHS also notes that some of these symptoms are very common and can be caused by other conditions, so having them does not mean you have bladder cancer, but getting them looked at is the step you control. NHS
Be Skeptical of Diet Claims: Most of what is reliably known about lowering bladder cancer risk concerns avoiding carcinogens rather than diet. Drinking more fluid is often suggested on the theory that it dilutes urine, but a meta-analysis of 21 studies found no overall association between total fluid intake and bladder cancer (OR 1.06, 95% CI 0.88 to 1.27, highest versus lowest intake), and the authors concluded there was no convincing evidence for the association given the limitations of the individual studies. That does not make hydration or a good diet a bad idea, it just means neither is established bladder cancer prevention. Beyond tobacco and occupational exposure, this is not a condition where lifestyle explains most of the risk. World Journal of Surgical Oncology (PMC)
How much of this is genetic?
Genetics explains 30% of why people differ in this trait. The rest is environment, daily habits and chance.
Heritability estimate: Nordic Twin Study of Cancer (Mucci et al., JAMA 2016): bladder/urinary heritability ~30%
Background and further reading
Bladder cancer is a malignancy that begins in the cells lining the inside of the bladder, most commonly urothelial (transitional cell) carcinoma. It is among the ten most common cancers worldwide and occurs roughly three to four times more often in men than in women. The most frequent early sign is blood in the urine (hematuria), which is often painless, along with changes in urinary frequency or urgency. Most cases are diagnosed as non-muscle-invasive disease, which tends to recur but is frequently manageable; a smaller share are muscle-invasive at diagnosis and more serious. Incidence rises steadily with age, with most diagnoses after age 55.
Genetic Basis: Heritability of bladder cancer is modest. Twin and family studies place the genetic contribution at roughly 30%, meaning environmental and lifestyle exposures account for the majority of variation in who develops the disease. Genome-wide association studies have identified a number of common susceptibility loci, and several of the strongest signals involve genes that metabolize and detoxify chemical carcinogens. Notable examples include NAT2, where the slow-acetylator genotype impairs clearance of aromatic amines, and the GSTM1-null deletion, which reduces detoxification capacity. Additional loci near PSCA, TP63, TERT-CLPTM1L, UGT1A, and MYC contribute smaller effects, and a polygenic score sums many such variants to estimate overall genetic tendency.
Environmental Factors: Bladder cancer is one of the cancers most strongly tied to modifiable exposures. Tobacco smoking is by far the leading factor and is estimated to account for around half of all cases, because carcinogens from smoke are filtered by the kidneys and concentrated in the bladder. Occupational exposure to aromatic amines and other industrial chemicals (historically in dye, rubber, leather, and painting industries) also raises risk, as does chronic exposure to arsenic in drinking water. Because inherited risk-metabolism genes like NAT2 and GSTM1 interact with these same chemical exposures, genetics and environment combine: the effect of smoking on bladder cancer is amplified in people carrying slower-detoxifying variants, which makes avoiding tobacco especially meaningful.
The published research behind your score, and the variants it draws on.
7 published scores from 3 studies
The bladder cancer score combines 7 polygenic scores drawn from 3 published studies.
These traits are influenced by some of the same genes and variants as this one
Body Mass Index: A measure of body weight relative to height, used as a proxy for overall adiposity.
Leukemia: A cancer of the blood-forming tissues, represented here mainly by lymphoid leukemia.
Content updated August 2026.
ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.
Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026
Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com